Unjha Formul, a company in the Pharmaceuticals industry, reported revenue of ₹4.41 crore and net profit of ₹0.51 crore for the September 2026 quarter.
Unjha Formul. (BSE: UNJHAFOR) closed at ₹27.45 on 20 Nov 2026, up 8.1% over the past year. Its market capitalisation is ₹12 crore and it trades at 72.3 times earnings.
Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.